UPR signaling is initiated by three ER transmembrane proteins: IRE1α, PERK, and ATF6. The most ancient ER stress sensor, IRE1α, contains an ER lumenal domain, a cytosolic kinase domain and a cytosolic RNase domain [
9,
10]. In the presence of unfolded proteins, IRE1α’s ER lumenal domains homo-oligomerize, leading first to kinase trans-autophosphorylation and subsequent RNase activation. Dissociation of the ER chaperone BiP from IRE1α’s lumenal domain in order to engage unfolded proteins may facilitate IRE1α oligomerization [
11]; alternatively, the lumenal domain may bind unfolded proteins directly [
12]. PERK’s ER lumenal domain is thought to be activated similarly [
13,
14]. The ATF6 activation mechanism is less clear. Under ER stress, ATF6 translocates to the Golgi and is cleaved by Site-1 and Site-2 proteases to generate the ATF6(N) transcription factor [
15].
All three UPR sensors have outputs that attempt to tilt protein folding demand and capacity back into homeostasis. PERK contains a cytosolic kinase that phosphorylates eukaryotic translation initiation factor 2α (eIF2α), which impedes translation initiation to reduce the protein load on the ER [
16]. IRE1α splices
XBP1 mRNA, to produce the homeostatic transcription factor XBP1s [
17,
18]. Together with ATF6(N), XBP1s increases transcription of genes that augment ER size and function[
19]. When eIF2α is phosphorylated, the translation of the activating transcription factor-4 (ATF4) is actively promoted and leads to the transcription of many pro-survival genes [
20]. Together, these transcriptional events act as homeostatic feedback loops to reduce ER stress. If successful in reducing the amount of unfolded proteins, the UPR attenuates.
However, when these adaptive responses prove insufficient, the UPR switches into an alternate mode that promotes apoptosis. Under irremediable ER stress, PERK signaling can induce ATF-4-dependent upregulation of the CHOP/GADD153 transcription factor, which inhibits expression of the gene encoding anti-apoptotic BCL-2 while upregulating the expression of oxidase ERO1α to induce damaging ER oxidation [
21,
22]. Sustained IRE1α oligomerization leads to activation of apoptosis signal-regulating kinase 1 (ASK1) and its downstream target c-Jun NH
2-terminal kinase (JNK) [
23,
24]. Phosphorylation by JNK has been reported to both activate pro-apoptotic BIM and inhibit anti-apoptotic BCL-2 (see below). Small molecule modulators of ASK1 have been shown to protect cultured cells against ER stress-induced apoptosis, emphasizing the importance of the IRE1α-ASK1-JNK output as a death signal in this pathway [
25]. In response to sustained oligomerization, the IRE1α RNase also causes endonucleolytic decay of hundreds of ER-localized mRNAs [
26]. By depleting ER cargo and protein folding components, IRE1α-mediated mRNA decay may worsen ER stress, and could be a key aspect of IRE1α’s pro-apoptotic program [
27]. Recently, inhibitors of IRE1α’s kinase pocket have been shown to conformationally activate its adjacent RNase domain in a manner that enforces homeostatic XBP1s without causing destructive mRNA decay [
27], a potentially exciting strategy for preventing ER stress-induced cell loss.
When deciding whether to switch into apoptotic mode, cells might use one or more “timers” to indicate if UPR signaling remains continuously active under high or chronic ER stress. For example, sustained PERK activity could result in protracted translation attenuation, which should be incompatible with survival, as well as high levels of pro-apoptotic CHOP. Similarly, high-level mRNA degradation mediated by IRE1α may deplete ER protein folding capacity further, and along with JNK signaling push the cell towards apoptosis. Thus, the continuous activation of the proximal sensors IRE1α and PERK may constitute a “timer” that triggers the switch to apoptosis under irremediable ER stress. Moreover, the ultimate response may depend on cell context. For example, the ability of IRE1α to complex with regulators such as BAX/BAK and Bax Inhibitor 1 (BI-1) at the ER may influence its ability to remediate ER stress and/or potentially signal apoptosis [
28,
29].